STTK · Shattuck Labs, Inc.
$7.37
-0.55 (-6.94%)
At close · Aug 5
Market Cap
$565.14M
Shares
76.68M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$7.37
Open$7.92
Day$7.33–7.92
52W$0.71–8.33
Avg vol 30d1.7M
Short int7.8M · 10.2% float · 5.8d
Short vol36%
Last earningsNov 9, 2023
DataOct 2020–Aug 2026
Filing10-Q · May 7
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 7, 2026
Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Strong Buy
Momentum
Very Strong
Sentiment
Bullish
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 15.8 · calm
Equity put/call 0.46
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+51%
above
Price vs 50-day avg
+20%
above
RSI (14)
56
neutral
MACD trend
Positive
52-week position
87%
near high
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+7%
trailing
6-month return
+80%
trailing
YTD return
+102%
this year
Relative strength
+69%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $6 › 200d $5 — 50d above 200d
Institutional flow
Accumulating
18 of 81 funds reported for Jun 30 · net +1.1M sh shares · +8 new
Insider flow
Accumulating
Net +$37.5K over 90 days · 67% sells
Short interest
Rising
10.18% of float · ▲ +31.6% MoM · 5.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
81 holders — near 3-yr high, broad support
Squeeze score
77
high risk · 0–100
Fundamentals
Revenue growth
−83%
Y/Y
EPS growth
+53%
Y/Y
Free cash flow
$-40.0M
Balance sheet
$54.2M
net cash
Quant / Vol
risk profile
Volatility
98%
annualized · 1-yr
Max drawdown
−51%
past year
ATR
8.1%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+51%
Bullish
Price vs 50-day avg
+20%
Bullish
RSI (14)
56
Neutral
MACD trend
Positive
Bullish
52-week position
87%
Bullish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $6 › 200d $5 — 50d above 200d
Institutional flow
Accumulating
18 of 81 funds reported for Jun 30 · net +1.1M sh shares · +8 new
Insider flow
Accumulating
Net +$37.5K over 90 days · 67% sells
Short interest
Rising
10.18% of float · ▲ +31.6% MoM · 5.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
81 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $1
Now $7 · 87%
52-wk high $8
vs 200-day avg +51%
vs 50-day avg +20%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
STTK
this stock
Shattuck Labs, Inc.
|
$565.14M | +101.9% | -82.5% | — | 10.2% |
|
ONC
BeOne Medicines Ltd.
|
$484.13B | +7.8% | +22179.2% | 744.4 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$122.89B | +6.9% | +46.2% | 28.2 | 2.0% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$79.13B | -0.2% | +20.8% | 19.0 | 3.4% |
|
ARGX
Argenx SE
|
$54.30B | +3.2% | — | — | 2.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| STTK | +9.0% | +7.1% | +80.2% | +4.2% | +101.9% |
| SPY | +5.5% | +3.3% | +11.3% | +3.1% | +12.9% |
| vs SPY | +3.5% | +3.9% | +69.0% | +1.2% | +89.0% |
Key facts
CIK
1680367
CUSIP
82024L103
13F (30d)
19 filings
19 filers
Visit website
Investor relations